Ivabradine and Blood Pressure Reduction: Underlying Pleiotropic Mechanisms and Clinical Implications
Main Authors: | Fedor Simko, Tomas Baka |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-02-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2021.607998/full |
Similar Items
-
Ivabradine Ameliorates Kidney Fibrosis in L-NAME-Induced Hypertension
by: Peter Stanko, et al.
Published: (2020-07-01) -
Effect of Ivabradine on a Hypertensive Heart and the Renin-Angiotensin-Aldosterone System in L-NAME-Induced Hypertension
by: Fedor Simko, et al.
Published: (2018-10-01) -
A possibility to interchange heart rate-slowing therapy with ivabradine and atenolol in patients with stable angina pectoris
by: A A Shavarov, et al.
Published: (2013-04-01) -
ENDOTHELIAL DYSFUNCTION AND NEUROHUMORAL REGULATION OF BLOOD PRESSURE IN PATIENTS WITH SYSTEMIC SCLEROSIS
by: N. P. Shilkina, et al.
Published: (2019-09-01) -
ASSESSMENT OF THE CHANGES IN BLOOD PRESSURE CIRCADIAN PROFILE AND VARIABILITY IN PATIENTS WITH CHRONIC HEART FAILURE AND ARTERIAL HYPERTENSION DURING COMBINED THERAPY INCLUDING IVABRADINE
by: M. V. Surovtseva, et al.
Published: (2015-12-01)